REFINEMENT OF NEW ASSAYS FOR DIRECT DETECTION OF NUCLEIC
$0N01FY2000HBNIH
Gen-Probe, Inc., San Diego CA
Investigators
Linked publications & trials
Abstract
The objective of the study are: 1) to refine for use in blood bank laboratories, organ donor centers, and hospital laboratories, an amplification and detection system which will simultaneously identify the presence of human immunodeficiency virus (HIV-1) and hepatitis C virus (HCV) nucleic acids in donors of organs for transplantation and close the window period between infectivity and detection to the shorted possible time; and 2) to file for investigational new drug exemption (INDs) with Food and Drug Administration and submit and obtain approval for product license applications (PLAs).
View original record on NIH RePORTER →